- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01448629
Safety and Performance of a New 1-piece Ostomy Product Compared to Standard Care Ostomy Products in Subjects Ileostomy
An Open-labelled, Randomised, Controlled, Comparative, Explorative, Cross-over Study Investigating Safety and Performance of a New 1-piece Ostomy Product Compared Standard Care Ostomy Products in Subjects With Ileostomy
Introduction:
It is not an illness to have an ostomy, even though it is an indication of previous serious illness, such as cancer, which is the reason for approximately 80% of all ostomy operations. Ostomies can be divided into three categories: colostomy (large intestine), ileostomy (small intestine) and urostomy (urinary tract). All require surgical redirection of the intestine or urinary tract, allowing for elimination of urine and faeces by means of an opening in the abdominal wall. For the population included in this study, subject with an ileostomy, colitis ulcerosa is the main cause for an ileostomy where a surgical removal of the colon and rectum resulting in an ileostomy in theory cures the disease.
It can be very challenging to live with an ostomy and modern ostomy products should make life as easy as possible for people with ostomies.
Leakage and peristomal skin problems have been found to have a negative effect on the quality of life for people with ostomies. The skin problems are the reason for one out of three visits to ostomy nurses and occur much more frequently in people who have had ileostomies than in those who have had colostomies. It has been observed that the prevalence of peristomal skin problems is 21-60% among people who have ileostomies, 13-35% among those who have colostomies and 21-48% among those who have urostomies.
Leakage from ostomies that comes into contact with the skin is thought to predispose the patient to peristomal skin problems. One investigation of peristomal skin problems found that 77% of cases were related to contact with faeces or urine.
There are several reasons why leakage from an ostomy occurs, such as uneven peristomal area, improper handling of the ostomy product or a problematic ostomy (its formation, its location, retraction, prolapse or hernia). The ostomy may also change size with time, which can lead to leakage, if the ostomy products are not adapted accordingly. As a general rule, a check-up of the ostomy by an ostomy nurse or a doctor together with educational support can reduce these problems. Modern ostomy products should, however, also be constantly developed in order to lessen to the greatest extent possible the risk of leakage and associated inconveniences.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
List of Inclusion Criteria:
- Have given written informed consent.
- Are at least 18 years old.
- Have mental capacity to understand the study guidelines and questionnaires.
- Have had their ileostomy for at least 3 months
- Have an ileostomy with a diameter be-tween 19-40 mm.
- Are currently using a flat 1-piece product.
- Are able to change the product by them-selves or with help from a caregiver (e.g. spouse)
- Have experienced leakage under the base plate at least once a week over the last 2 weeks.
List of Exclusion criteria.
- Pregnant or breast-feeding.
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
- Currently using topical steroid product on peristomal skin (injections and oral treatment are accepted).
- Are currently using a convex product
- Participating in other clinical studies or have previously participated in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: River
|
River is a new developed product with Coloplast as manufacturer
|
Active Comparator: Standard Care
Standard Care can have several manufacture and brand names.
Standard Care is defined af the participants currently used stoma care product.
|
Participants are using their own product and this procedure is called "Standard Care". Standard Care are the participants own products and may consist of several manufacturer and brand names. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Leakage underneath the baseplate
Time Frame: two weeks
|
two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peristomal skin condition
Time Frame: Two weeks
|
Measured by the Ostomy Skin Tool
|
Two weeks
|
Security
Time Frame: Two weeks
|
The participants feeling of security when wearing the product, measured on a 5-point scale
|
Two weeks
|
Handling
Time Frame: Two weeks
|
The participants ease of handling the products, measured on a 5-point scale
|
Two weeks
|
Comfort
Time Frame: Two weeks
|
The participants feeling of comfort when wearing the product, measured on a 5-point scale
|
Two weeks
|
Adverse events
Time Frame: Two weeks
|
Two weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Carol Katte, MD, Ashford and St. Peters Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP214OC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Condition
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedPrecancerous/Nonmalignant ConditionUnited States
-
AI Labs Group S.LOsakidetza; Hospital Universitario Cruces; Servicio Vasco de Salud Osakidetza...RecruitingSkin Diseases | Skin ConditionSpain
-
TCI Co., Ltd.Recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Active, not recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
Clinical Trials on River
-
Ology BioservicesCompletedProphylaxis of Ross River Virus InfectionAustralia
-
Ology BioservicesCompleted
-
Serenity Medical, Inc.Active, not recruitingIdiopathic Intracranial HypertensionUnited States
-
Sun Yat-sen UniversityTerminatedTriple Negative Breast CancerChina
-
The Third Xiangya Hospital of Central South UniversityNot yet recruitingCharcot-Marie-Tooth Disease (CMT)
-
Ology BioservicesCompletedRoss River Virus Disease (RRVD)Netherlands, Austria, Belgium